Skip to Content
Merck
  • Uveal effusion as a mechanism of bilateral angle-closure glaucoma induced by chlorthalidone.

Uveal effusion as a mechanism of bilateral angle-closure glaucoma induced by chlorthalidone.

Journal of glaucoma (2014-01-23)
James R Singer, Zachary D Pearce, Scott J Westhouse, Karl J Siebert
ABSTRACT

To report a novel case of acute bilateral uveal effusions, angle closure, and acute myopia induced by administration of chlorthalidone. Case report. Bilateral shallow anterior chambers, high intraocular pressure, and a myopic shift were encountered in a patient 1 week after initiation of chlorthalidone. Ultrasound evaluation revealed bilateral ciliochoroidal effusions, appositional angle closure, and suspected ciliary body edema. Cessation of chlorthalidone, in addition to administration of cycloplegics and ocular antihypertensives, resulted in prompt resolution of this idiosyncratic reaction. The antihypertensive medication chlorthalidone may cause bilateral uveal effusions inducing acute angle-closure glaucoma and acute myopia.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Chlorthalidone, ≥98% (HPLC)
Chlorthalidone, European Pharmacopoeia (EP) Reference Standard
USP
Chlorthalidone, United States Pharmacopeia (USP) Reference Standard